Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2RL3 | Q96RI0 | 11/20 | 0.71 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PRMT7 | Q9NVM4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30187592 | 0.85 | F2RL3 (0.76) | F2RL3MAOAMAOBKMT2A | |
| SCHEMBL19783498 | 0.85 | F2RL3 (0.76) | F2RL3MAOAMAOBKMT2A | |
| SCHEMBL30187680 | 0.83 | F2RL3 (1.00) | F2RL3MAOAMAOBTOP2AMKNK1 | |
| SCHEMBL19783233 | 0.83 | F2RL3 (1.00) | F2RL3MAOAMAOBTOP2AMKNK1 | |
| SCHEMBL30189861 | 0.83 | F2RL3 (0.67) | F2RL3TOP2AMKNK1 | |
| SCHEMBL19782893 | 0.83 | F2RL3 (0.67) | F2RL3TOP2AMKNK1 | |
| SCHEMBL30187691 | 0.83 | F2RL3 (0.73) | F2RL3MAOAMAOBTOP2APDE4D | |
| SCHEMBL19783803 | 0.83 | F2RL3 (0.73) | F2RL3MAOAMAOBTOP2APDE4D | |
| SCHEMBL19783468 | 0.80 | F2RL3 (0.69) | F2RL3MAOBPOLBKMT2A | |
| SCHEMBL30189527 | 0.80 | F2RL3 (0.69) | F2RL3MAOBPOLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018013774-A1 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-01-18 | — | — | WO | disclosed |